Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
NEJM 376:209-220,280, Montalban, X.,et al, 2017
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
NEJM 367:1098-1106,1149, Gold, R.,et al, 2012
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
NEJM 367:1087-1097,1149, Fox, R.J.,et al, 2012
Fatigue Therapy in Multiple Sclerosis:A Double-blind, Randomized, Parallel Trial of Amantadine, Pemoline & Placebo
Neurol 45:1956-1961, Krupp,L.B.,et al, 1995
Ethical Use of Placebos and Provocative Testing in Diagnosing Nonepileptic Seizures
Neurol 47:866-870, Devinsky,O.&Fisher,R., 1996
Utility and Reliability of Placebo Infusion in the Evaluation of Patients with Seizures
neurol 44:394-399, Walczak,T.S.,et al, 1994